These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38339872)

  • 21. Confidence intervals for confirmatory adaptive two-stage designs with treatment selection.
    Bebu I; Dragalin V; Luta G
    Biom J; 2013 May; 55(3):294-309. PubMed ID: 23553644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On construction of smallest one-sided confidence intervals for the response rate in adaptive two- or multi-stage designs.
    Wang W; Yin H; Zhang Z
    Stat Methods Med Res; 2020 Jun; 29(6):1682-1699. PubMed ID: 32491977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adaptive designs at European Organisation for Research and Treatment of Cancer (EORTC) with a focus on adaptive sample size re-estimation based on interim-effect size.
    Mauer M; Collette L; Bogaerts J;
    Eur J Cancer; 2012 Jun; 48(9):1386-91. PubMed ID: 22281098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adaptive trial designs.
    Lai TL; Lavori PW; Shih MC
    Annu Rev Pharmacol Toxicol; 2012; 52():101-10. PubMed ID: 21838549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal unplanned design modification in adaptive two-stage trials.
    Pilz M; Herrmann C; Rauch G; Kieser M
    Pharm Stat; 2022 Nov; 21(6):1121-1137. PubMed ID: 35604767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Bayesian Hybrid Adaptive Randomisation Design for Clinical Trials with Survival Outcomes.
    Moatti M; Chevret S; Zohar S; Rosenberger WF
    Methods Inf Med; 2016; 55(1):4-13. PubMed ID: 26404511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interval and point estimation in adaptive Phase II trials with binary endpoint.
    Nhacolo A; Brannath W
    Stat Methods Med Res; 2019 Sep; 28(9):2635-2648. PubMed ID: 29921157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal adaptive sequential designs for crossover bioequivalence studies.
    Xu J; Audet C; DiLiberti CE; Hauck WW; Montague TH; Parr AF; Potvin D; Schuirmann DJ
    Pharm Stat; 2016; 15(1):15-27. PubMed ID: 26538182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flexible design of two-stage adaptive procedures for phase III clinical trials.
    Koyama T
    Contemp Clin Trials; 2007 Jul; 28(4):500-13. PubMed ID: 17307399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Planning and analyzing adaptive group sequential survival trials.
    Wassmer G
    Biom J; 2006 Aug; 48(4):714-29. PubMed ID: 16972724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival endpoints and adaptive designs.
    Bauer P
    Biom J; 2006 Aug; 48(4):730-1. PubMed ID: 16972725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An adaptive two-arm clinical trial using early endpoints to inform decision making: design for a study of sub-acromial spacers for repair of rotator cuff tendon tears.
    Parsons N; Stallard N; Parsons H; Wells P; Underwood M; Mason J; Metcalfe A
    Trials; 2019 Dec; 20(1):694. PubMed ID: 31815651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adaptive clinical trial designs with pre-specified rules for modifying the sample size: understanding efficient types of adaptation.
    Levin GP; Emerson SC; Emerson SS
    Stat Med; 2013 Apr; 32(8):1259-75; discussion 1280-2. PubMed ID: 23081665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adaptive designs for noninferiority trials.
    Gao P; Liu L; Mehta C
    Biom J; 2013 May; 55(3):310-21. PubMed ID: 23494872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adaptive Optimal Designs for Dose-Finding Studies with Time-to-Event Outcomes.
    Ryeznik Y; Sverdlov O; Hooker AC
    AAPS J; 2017 Dec; 20(1):24. PubMed ID: 29285730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adaptive two-stage designs in phase II clinical trials.
    Banerjee A; Tsiatis AA
    Stat Med; 2006 Oct; 25(19):3382-95. PubMed ID: 16479547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A variational approach to optimal two-stage designs.
    Pilz M; Kunzmann K; Herrmann C; Rauch G; Kieser M
    Stat Med; 2019 Sep; 38(21):4159-4171. PubMed ID: 31264243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal adaptive two-stage designs for early phase II clinical trials.
    Shan G; Wilding GE; Hutson AD; Gerstenberger S
    Stat Med; 2016 Apr; 35(8):1257-66. PubMed ID: 26526165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Start-up designs for response-adaptive randomization procedures with sequential estimation.
    Haines LM; Sadiq H
    Stat Med; 2015 Sep; 34(21):2958-70. PubMed ID: 25944171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Point estimation and p-values in phase II adaptive two-stage designs with a binary endpoint.
    Kunzmann K; Kieser M
    Stat Med; 2017 Mar; 36(6):971-984. PubMed ID: 28028823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.